NCT05968729 Assessment of Gait Adaptation Due to an Asymmetric Walking Protocol
| NCT ID | NCT05968729 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Connecticut |
| Condition | Anterior Cruciate Ligament Reconstruction |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2022-09-01 |
| Primary Completion | 2027-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2022-09-01 with a primary completion date of 2027-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this work is to conduct a comparative research-focused study to evaluate the effectiveness of how purposefully induced asymmetric walking protocols restore healthy, symmetric limb loading in individuals following post-anterior cruciate ligament reconstruction (ACLR) surgery. Additionally, computational modeling and machine learning to model knee loading in the clinic to determine the optimal asymmetric walking protocol to restore healthy gait in post-ACLR individuals.
Eligibility Criteria
Inclusion Criteria: 1. Able to read and speak English 2. Age 18 - 30 years old 3. Undergone ACLR surgery at the UConn Musculoskeletal Institute 4. Must not have any concomitant surgeries or injuries 5. Must be cleared to return-to-sport by a physician after they have completed rehabilitation 6. Must be within 1 month of having been cleared for return-to-sport 7. Must present with between-limb gait differences in load rate greater than 10% Exclusion Criteria: 1. Participants who have any recent inflammation, bleeding disorders, active bleeding, or infection within the lower limbs. 2. History of injuries to their patellar tendon 3. Cannot walk for extended periods of time 4. Cannot have had any back and/or lower extremity injury that affects their ability to move. 5. Cannot have difficulty or pain with walking, raising your arms, jogging, or jumping 6. Must not be allergic to tape.
Contact & Investigator
Kristin Morgan, PhD
PRINCIPAL INVESTIGATOR
University of Connecticut
Frequently Asked Questions
Who can join the NCT05968729 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 30 Years, studying Anterior Cruciate Ligament Reconstruction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05968729 currently recruiting?
Yes, NCT05968729 is actively recruiting participants. Contact the research team at kristin.2.morgan@uconn.edu for enrollment information.
Where is the NCT05968729 trial being conducted?
This trial is being conducted at Storrs, United States.
Who is sponsoring the NCT05968729 clinical trial?
NCT05968729 is sponsored by University of Connecticut. The principal investigator is Kristin Morgan, PhD at University of Connecticut. The trial plans to enroll 40 participants.